FDA 483 - Hill Dermaceuticals, Inc. - October 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Hill Dermaceuticals, Inc. in Sanford, FL, was inspected and cited for significant deficiencies across its manufacturing operations and supply chain security. Observations included poorly maintained equipment and facilities posing contamination risks, inadequate calibration controls for critical instruments, and a complete lack of systems to comply with Drug Supply Chain Security Act verification requirements. These issues indicate a serious lapse in maintaining a state of control over drug product quality and traceability.
ID · a50aef9d-f4a0-4b75-98bb-3747db7aab0a